Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? infection

Clinical Orthopaedics and Related Research

Volumn 470, Issue 10, 2012, Pages 2702-2707

  Sewick, Amy ^a   Makani, Amun ^a   Wu, Chia ^a   O'Donnell, Judith ^b   Baldwin, Keith D ^a   Lee, Gwo Chin ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; BACTERIUM CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DUAL ANTIBIOTIC PROPHYLAXIS; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK REDUCTION; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; TOTAL JOINT ARTHROPLASTY; TOTAL KNEE REPLACEMENT;

EID: 84866431433     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-012-2255-1     Document Type: Conference Paper

References (41)

1. American Academy of Orthopaedic Surgeons Advisory Statement: Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. Available at: http://www.aaos.org/about/papers/ advistmt/1027.asp. Accessed August 27, 2011.
2. Ayliffe GA. Role of the environment of the operative suite in surgical wound infection. Rev Infect Dis. 1991;13(Suppl. 10):S800-S804.
3. Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection. J Bone Joint Surg Am. 2006;88:869-882.
4. Boxma H, Broekhuizen T, Patka P, Oosting H. Randomized control trial of a single dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial. Lancet. 1996;347:1133-1137. (Pubitemid 126512040)
5. Bozic KJ, Katz P, Cisternas M, Ono L, Ries MD, Showstack J. Hospital resource utilization for primary and revision total hip arthroplasty. J Bone Joint Surg Am. 2005;87:570-576. (Pubitemid 40315008)
6. Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91:128-133.
7. Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, Rubash HE, Berry DJ. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468:45-51.
8. Bratzler DW, Houck PM; Surgical Infection Prevention Guideline Writers Workgroup. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg. 2005;189:395-404. (Pubitemid 40488232)
9. Dale WB, Peter MH. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706-1715. (Pubitemid 38781662)
10. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-1429. (Pubitemid 38419996)
11. Douglas P, Asimus M, Swan J, Spigelman A. Prevention of orthopaedic wound infections: a quality improvement project. J Qual Clin Pract. 2001;21:149-153. (Pubitemid 34139826)
12. Dreghorn CR, Hamblen DL. Revision arthroplasty: a high price to pay. BMJ. 1989;296:648-649. (Pubitemid 19088525)
13. Fierobe L, Decré D, Mùller C, Lucet JC, Marmuse JP, Mantz J, Desmonts JM. Methicillin-resistant Staphylococcus aureus as a causative agent of postoperative intra-abdominal infection: relation to nasal colonization. Clin Infect Dis. 1999;29:1231-1238. (Pubitemid 30265644)
14. Finkelstein R, Rabino G, Mashiah T, Bar-El Y, Adler Z, Kertzman V, Cohen O, Milo S. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123:326-332. (Pubitemid 34127121)
15. Gavin KL, Konigsberg BS. Infection following total knee arthroplasty: prevention and management. J Bone Joint Surg Am. 2011;93:1167-1175.
16. Gobran SR, Goldman S, Ferdinand F, Wertan MA, Trace C, Grunkemeier GL, Wu Y, Sutter FP. Outcomes after usage of a quality initiative program for off-pump coronary artery bypass surgery; a comparison with on-pump surgery. Ann Thorac Surg. 2004;78:2015-2021. (Pubitemid 39556282)
17. Gupta K, Strymish J, Abi-Haidar Y, Williams SA, Itani KM. Preoperative nasal methicillin-resistant Staphylococcus aureus status, surgical prophylaxis, and risk-adjusted postoperative outcomes in veterans. Infect Control Hosp Epidemiol. 2011;32:791-796.
18. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13:606-608.
19. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006;88:2487-2500. (Pubitemid 44713839)
20. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC. Institutional prescreening for detection and eradication of MRS in patients undergoing elective orthopaedic surgery. J Bone Joint Surg Am. 2010;92:1820-1826.
21. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988;318:1728-1733.
22. Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2011;469:1009-1015.
23. Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effects of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed). 1982;285:10-14. (Pubitemid 12080387)
24. Lynch RJ, Englesbe MJ, Sturm L, Bitar A, Budhiraj K, Kolla S, Polyachenko Y, Duck MG, Campbell DA Jr. Measurement of foot traffic in the operating room: implications for infection control. Am J Med Qual. 2009;24:45-52.
25. Malangoni MA, Cheadle WG, Dodson TF, Dohmen PM, Jones D, Katariya K, Kolvekar S, Urban JA. New opportunities for reducing risk of surgical site infection. Surg Infect (Larchmt). 2006;7(Suppl. 1):S23-S39.
26. Mangram AJ. A brief overview of the 1999 CDC guideline for the prevention of surgical site infection: centers for disease control and prevention. J Chemother. 2001;13:35-39. (Pubitemid 34183591)
27. Marculescu CE, Osmon DR. Antibiotic prophylaxis in orthopaedic prosthetic surgery. Infect Dis Clinic N Am. 2009;19:931-946. (Pubitemid 41627498)
28. Meehan J, Jamali AA, Nguyen, H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am. 2009;91:2480-2489.
29. Merrer J, Desbouchages L, Serazin V, Razafimamonjy J, Pauthier F, Leneveu M. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes. Infect Control Hosp Epidemiol. 2006;27:1366-1371. (Pubitemid 46052284)
30. Miller LG, McKinnell JA, Vollmer ME, Spellberg B. Impact of methicillin-resistant Staphylococcus aureus prevalence among S. aureus isolates on surgical site infection risk after coronary artery bypass surgery. Infect Control Hosp Epidemiol. 2011;32:342-350.
31. Peel TN, Dowsey MM, Daffy JR, Stanley PA, Choong PF, Buising KL. Risk factors for prosthetic hip and knee infections according to arthroplasty site. J Hosp Infect. 2011;79:129-133.
32. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9:196-203. (Pubitemid 36231790)
33. Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg. 2008;16:283-293.
34. Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844-850. (Pubitemid 40862073)
35. Ritter MA, Barzilauskas CD, Faris PM, Keating PM. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics. 1989;12:1333-1336. (Pubitemid 19264559)
36. Thomas C, Cadwallader HL, Riley TV. Surgical-site infections after orthopaedic surgery: statewide surveillance using linked administrative databases. J Hosp Infect. 2004;57:25-30. (Pubitemid 38594517)
37. Tyllianakis ME, Karageorgos ACh, Marangos MN, Saridis AG, Lambiris EE. Antibiotic prophylaxis in primary hip and knee arthroplasty: comparison between cefuroxime and two specific antistaphylococcal agents. J Arthroplasty. 2010;25:1078-1082.
38. van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, Wille JC, Gyssens IC. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother. 2005;56:1094-1102. (Pubitemid 43009826)
39. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011;171:68-73.
40. Wiesel BB, Esterhai JJ. Chapter 4: Prophylaxis of musculoskeletal infection. In Calhoun JJ and Mader JT (eds). Musculoskeletal Infections. Marcel Dekker, Inc., New York, NY. 2003;115-129.
41. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-1654. (Pubitemid 39350425)